NO20062757L - Syntesemetode for reduktiv alkulering i C-3 stilling pa indoler - Google Patents

Syntesemetode for reduktiv alkulering i C-3 stilling pa indoler

Info

Publication number
NO20062757L
NO20062757L NO20062757A NO20062757A NO20062757L NO 20062757 L NO20062757 L NO 20062757L NO 20062757 A NO20062757 A NO 20062757A NO 20062757 A NO20062757 A NO 20062757A NO 20062757 L NO20062757 L NO 20062757L
Authority
NO
Norway
Prior art keywords
indoles
reductive
alkalination
synthesis method
indole
Prior art date
Application number
NO20062757A
Other languages
English (en)
Norwegian (no)
Inventor
Panolil Raveendranath
Ronald Stanley Michalak
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20062757L publication Critical patent/NO20062757L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20062757A 2003-12-16 2006-06-13 Syntesemetode for reduktiv alkulering i C-3 stilling pa indoler NO20062757L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52979703P 2003-12-16 2003-12-16
PCT/US2004/041989 WO2005058820A1 (fr) 2003-12-16 2004-12-15 Methodologie synthetique destinee a l'alkylation reductrice a la position c-3 d'indoles

Publications (1)

Publication Number Publication Date
NO20062757L true NO20062757L (no) 2006-06-28

Family

ID=34700047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062757A NO20062757L (no) 2003-12-16 2006-06-13 Syntesemetode for reduktiv alkulering i C-3 stilling pa indoler

Country Status (26)

Country Link
US (2) US7282594B2 (fr)
EP (1) EP1697320B1 (fr)
JP (1) JP5121232B2 (fr)
KR (2) KR20120082477A (fr)
CN (1) CN1914170B (fr)
AR (1) AR046895A1 (fr)
AU (1) AU2004299462B2 (fr)
BR (1) BRPI0417769B8 (fr)
CA (1) CA2549120C (fr)
CR (1) CR8446A (fr)
EC (1) ECSP066648A (fr)
EG (1) EG24473A (fr)
GT (1) GT200400266A (fr)
HN (1) HN2004000536A (fr)
IL (1) IL176147A (fr)
MX (1) MXPA06006669A (fr)
NI (1) NI200600132A (fr)
NO (1) NO20062757L (fr)
PA (1) PA8620101A1 (fr)
PE (1) PE20051012A1 (fr)
RU (1) RU2352560C2 (fr)
SG (1) SG147487A1 (fr)
TW (1) TW200526576A (fr)
UA (1) UA84445C2 (fr)
WO (1) WO2005058820A1 (fr)
ZA (1) ZA200604966B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
TW200510305A (en) * 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
US7582771B2 (en) * 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
AR053410A1 (es) * 2004-08-19 2007-05-09 Wyeth Corp Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos. compuestos intermediarios
TW200718687A (en) 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
WO2008055148A2 (fr) * 2006-10-31 2008-05-08 Wyeth Formulations demi-solides d'inhibiteurs de l'enzyme phospholipase
AU2007313706A1 (en) * 2006-10-31 2008-05-08 Wyeth Liquid formulations of phospholipase enzyme inhibitors
CN111087340B (zh) * 2019-11-29 2021-12-07 上海应用技术大学 一种维拉佐酮中间体的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9317764D0 (en) 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
US7101875B2 (en) 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
WO2003048122A2 (fr) * 2001-12-03 2003-06-12 Wyeth Inhibiteurs de phospholipase a2 cytosolique
US6984735B2 (en) 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US6635771B2 (en) 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
US6797708B2 (en) 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US20040182785A1 (en) * 2002-10-23 2004-09-23 Rigel Technology Corporation Animal plasma process by precipitation
TW200510305A (en) * 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
US7582771B2 (en) 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
AR053410A1 (es) 2004-08-19 2007-05-09 Wyeth Corp Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos. compuestos intermediarios
TW200718687A (en) 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2

Also Published As

Publication number Publication date
KR20120082477A (ko) 2012-07-23
TW200526576A (en) 2005-08-16
PA8620101A1 (es) 2006-03-24
CN1914170A (zh) 2007-02-14
BRPI0417769B1 (pt) 2019-12-17
NI200600132A (es) 2007-01-17
CA2549120C (fr) 2012-06-26
JP5121232B2 (ja) 2013-01-16
AR046895A1 (es) 2005-12-28
BRPI0417769B8 (pt) 2021-05-25
ZA200604966B (en) 2010-11-24
KR20070018820A (ko) 2007-02-14
US7709661B2 (en) 2010-05-04
ECSP066648A (es) 2006-10-25
AU2004299462A1 (en) 2005-06-30
HN2004000536A (es) 2009-02-18
JP2007514004A (ja) 2007-05-31
GT200400266A (es) 2005-08-30
US7282594B2 (en) 2007-10-16
IL176147A0 (en) 2006-10-05
CR8446A (es) 2006-12-07
BRPI0417769A8 (pt) 2018-05-08
BRPI0417769A (pt) 2007-04-17
AU2004299462B2 (en) 2011-07-14
IL176147A (en) 2011-12-29
CN1914170B (zh) 2010-07-14
PE20051012A1 (es) 2006-01-13
EP1697320A1 (fr) 2006-09-06
US20080161581A1 (en) 2008-07-03
CA2549120A1 (fr) 2005-06-30
US20050148770A1 (en) 2005-07-07
RU2006125447A (ru) 2008-01-27
MXPA06006669A (es) 2006-08-11
RU2352560C2 (ru) 2009-04-20
EP1697320B1 (fr) 2013-04-10
EG24473A (en) 2009-08-03
UA84445C2 (ru) 2008-10-27
KR101194592B1 (ko) 2012-10-25
SG147487A1 (en) 2008-11-28
WO2005058820A1 (fr) 2005-06-30

Similar Documents

Publication Publication Date Title
NO20062757L (no) Syntesemetode for reduktiv alkulering i C-3 stilling pa indoler
RS20050462A (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
MXPA05005139A (es) Nuevo proceso para la sintesis de (1s)-4,5-dimetoxi-1-(metilaminometil)-benzociclobutano y sales de adicion del mismo, y aplicacion en la sintesis de ivabradina y sales de adicion de la misma con un acido farmaceuticamente aceptable.
PL372799A1 (en) New compounds
MX2010002692A (es) Sintesis de catecoles deuterados y derivados de benzo[d][1,3]dioxoles de los mismos.
MY131574A (en) Method for producing catalysts consisting of metal of the platinum group by means of electroless deposition and the use thereof for the direct synthesis of hydrogen peroxide
SG127819A1 (en) Improved feeding tube
ATE340792T1 (de) Substituierte indole als alpha-1 agonisten
NO20065801L (no) Ekspanderende multiple rordeler
TNSN07463A1 (en) Process for the synthesis of organic compounds
IL223579A (en) METHOD FOR PRODUCING HISTORY OF (3-Hydroxy-1-Methyl-2-Oxo-3,2-Dihydro-1H-Indole-3-Il) -Acetic Acid and Several Compounds
TW200619205A (en) A method for preparing irbesartan and intermediates thereof
MY144180A (en) Method for producing strontium ranelate and its hydrates
AR051341A1 (es) Proceso para la preparacion de derivados de [1,4,5]-oxadiazepina
MY139159A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139348A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
HK1097525A1 (en) Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
IL193276A0 (en) Process for preparing 1-halo-2,7-naphthyridinyl derivatives
TW200733135A (en) Signal sampling apparatus and method for DRAM memory
MY139098A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139443A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
TWI265923B (en) Process for the preparation of 3-acylated indoles
MY136989A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application